Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 36. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_276AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay50 MOI90% cancer cell viability at 72 hoursNoNoNA No responseNANANANA26554307
OV_277AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay100 MOI90% cancer cell viability at 72 hoursNoNoNA No responseNANANANA26554307
OV_278AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI85% cancer cell viability at 72 hoursNoNoNA No responseNANANANA26554307
OV_279AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI83% cancer cell viability at 72 hoursNoNoNA No responseNANANANA26554307
OV_280AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI92% cancer cell viability at 24 hoursNoNoNA No responseNANANANA26554307
OV_281AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI94% cancer cell viability at 48 hoursNoNoNA No responseNANANANA26554307
OV_282AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI86% cancer cell viability at 96 hoursNoNoNA No responseNANANANA26554307
OV_291AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay50 MOI91% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_292AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay100 MOI85% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_293AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI65% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_294AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI56% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_295AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI92% cancer cell viability at 24 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_296AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI81% cancer cell viability at 48 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_297AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI61% cancer cell viability at 96 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_301AdenovirusAd.sp-E1ADNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP)YesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI100% cancer cell viability at 48 hoursNoNoNA No responseNANANANA26554307
OV_302AdenovirusAd.IL3DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-IL3 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI90% cancer cell viability at 48 hoursNoNoNA No responseNANANANA26554307
OV_303AdenovirusAd.4N1DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI80% cancer cell viability at 48 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_304AdenovirusAd.IL3DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-IL3 expression cassetteYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI100% cancer cell viability at 72 hoursNoNoNA No responseNANANANA26554307
OV_310AdenovirusAd.4N1-IL24DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 with IL-24 expression cassettesYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay50 MOI82% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_311AdenovirusAd.4N1-IL24DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 with IL-24 expression cassettesYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay100 MOI58% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_312AdenovirusAd.4N1-IL24DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 with IL-24 expression cassettesYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay150 MOI52% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_313AdenovirusAd.4N1-IL24DNAAdenoviridaeViral E1A promoter was replaced by human survivin promoter (hsurP) and contains a sCAR-4N1 with IL-24 expression cassettesYesNoNoATCCLeukemia cell lineHL-602.0E+4 cells per wellNAMTT assay200 MOI38% cancer cell viability at 72 hoursNoNoNA No responseNAInduces apoptosis by upregulating Bax and activated caspase 3 levelsInduces expression of IL-24NA26554307
OV_768AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI80% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_769AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI60% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_770AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI50% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_771AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI46% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_772AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI40% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_798AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI80% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_799AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI40% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_800AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI32% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_801AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI25% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_802AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineHL-601.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI20% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_2903Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoLaboratory grown own cultureLeukemia cell lineHL-605000 cells per wellNALuminiscent cell viability assay1 MOI100% cell viabilityNoNoNA No responseNAInduction of apoptosis by virus alone and in combinationNANA25193462
OV_2904Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoLaboratory grown own cultureLeukemia cell lineHL-605000 cells per wellNALuminiscent cell viability assay1 MOI75% cell viabilityNoNoNA No responseNAInduction of apoptosis by virus alone and in combinationNANA25193462
OV_2905Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles in combination with mumpsNoLaboratory grown own cultureLeukemia cell lineHL-605000 cells per wellNALuminiscent cell viability assay1 MOI40% cell viabiityNoNoNA No responseNAInduction of apoptosis by virus alone and in combinationNANA25193462
OV_4316AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman acute promyelocytic leukemiaHL-604000 cells per wellNAMTT assay10 pfu85.2 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347